Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Featured Broker Partners


Advertisement